SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Providing essential cancer care to rural communities

2.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

3.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

4.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

5.

How Do Younger People Fare With Stool Tests for CRC Screening?


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot